30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Scott Gottlieb

Track

Insider profile

Currently holds a position at Illumina Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 79% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Illumina Inc Feb. 4, 2020 -
Director EMI Holding Inc Aug. 3, 2015 - Jan. 1, 2018
Independent Director CombiMatrix Corp Jan. 15, 2009 - Dec. 19, 2016
Scott Gottlieb's trades of Illumina Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-11 2026-02-09
US Illumina Inc (ILMN)
B Purchase
40,841 +8.3%
88.15
US$845,553 		40,841 +8.3% 88.15 US$845,553
2025-11-05 2025-11-03
US Illumina Inc (ILMN)
B Purchase
98,560 +23.6%
265.39
US$1,633,231 		98,560 +23.6% 265.39 US$1,633,231
2025-04-03 2025-04-01
PlS Planned sale
80,881 -45.8%
397.88
US$470,293 		80,881 -45.8% 397.88 US$470,293
2025-04-03 2025-04-01
PlS Planned sale
4,000 -10.2%
48.13
US$192,520 		4,000 -10.2% 48.13 US$192,520
2025-04-03 2025-04-01
PlS Planned sale
16,273 -29.2%
47.10
US$766,458 		16,273 -29.2% 47.10 US$766,458
2025-04-03 2025-04-01
PlS Planned sale
5,006 -8.3%
46.07
US$230,626 		5,006 -8.3% 46.07 US$230,626
2025-03-19 2025-03-17
PlS Planned sale
7,102 -10.5%
50.45
US$358,296 		7,102 -10.5% 50.45 US$358,296
2025-03-19 2025-03-17
PlS Planned sale
6,698 -9.0%
49.72
US$333,025 		6,698 -9.0% 49.72 US$333,025
2025-03-19 2025-03-17
PlS Planned sale
6,349 -7.9%
48.44
US$307,546 		6,349 -7.9% 48.44 US$307,546
2025-03-19 2025-03-17
PlS Planned sale
3,077 -3.7%
47.53
US$146,250 		3,077 -3.7% 47.53 US$146,250
2025-03-19 2025-03-17
PlS Planned sale
4,612 -5.2%
46.59
US$214,873 		4,612 -5.2% 46.59 US$214,873
2025-03-17 2025-03-17
PrS Proposed sale
55,675
47.17
US$2,626,190 		55,675 47.17 US$2,626,190
2024-10-31 2024-10-30
US Pfizer Inc (PFE)
B Purchase
1,000 +11.1%
28.24
US$28,240 		1,000 +11.1% 28.24 US$28,240
2023-12-19 2023-12-15
US Pfizer Inc (PFE)
B Purchase
3,000 +50.0%
26.47
US$79,401 		3,000 +50.0% 26.47 US$79,401
2023-05-09 2023-05-08
US Pfizer Inc (PFE)
B Purchase
1,000 +20.0%
38.58
US$38,580 		1,000 +20.0% 38.58 US$38,580
2023-05-09 2023-05-05
US Pfizer Inc (PFE)
B Purchase
1,000 +25.0%
38.43
US$38,425 		1,000 +25.0% 38.43 US$38,425
2020-01-31 2020-01-30
US Pfizer Inc (PFE)
B Purchase
1,000 +33.3%
37.00
US$36,997 		1,000 +33.3% 37.00 US$36,997